(Q34674152)

3 August 2017

title

Depression, Cytokine, and Cytokine by Treatment Interactions Modulate Gene Expression in Antipsychotic Naïve First Episode Psychosis (English)

1 reference

3 August 2017

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26491028%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Leticia M Spindola

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26491028%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Rodrigo A. Bressan

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26491028%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Ary Gadelha

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26491028%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Sintia Iole Belangero

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26491028%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Michael Maes

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26491028%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

10

Elisa Brietzke

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26491028%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

2

Vanessa Kiyomi Ota

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26491028%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

3

Marcos Leite Santoro

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26491028%20AND%20SRC:MED&resulttype=core&format=json

Eduardo Sauerbronn Gouvea

5 June 2020

4

object named as

Eduardo Sauerbronn Gouvea

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26491028%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

Patricia Natalia Silva

5

object named as

Patricia Natalia Silva

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26491028%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

7

Quirino Cordeiro

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26491028%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

publication date

22 October 2015

1 reference

3 August 2017

published in

Molecular Neurobiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26491028%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

volume

53

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26491028%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26491028%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

5701-5709

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26491028%20AND%20SRC:MED&resulttype=core&format=json

Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010.

5 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Uncovering the hidden risk architecture of the schizophrenias: confirmation in three independent genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Neuroprogression in schizophrenia: Pathways underpinning clinical staging and therapeutic corollaries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Common and rare variants in multifactorial susceptibility to common diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Biological insights from 108 schizophrenia-associated genetic loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Genome-wide association analysis identifies 13 new risk loci for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Developmental neuroinflammation and schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Tumor necrosis factor-alpha mediated signaling in neuronal homeostasis and dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Tumor necrosis factor-alpha: a neuromodulator in the CNS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Effects of cytokines on cerebral neurotransmission. Comparison with the effects of stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

The therapeutic role of interleukin-10 after spinal cord injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

The interaction of nuclear factor-kappa B and cytokines is associated with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Roles of nuclear factor kappaB in neuronal survival and plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

DNA methyl transferase (DNMT) gene polymorphisms could be a primary event in epigenetic susceptibility to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Genome-wide DNA methylation analysis of human brain tissue from schizophrenia patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Effects of risperidone on cytokine profile in drug-naïve first-episode psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Oxidative stress in drug naïve first episode psychosis and antioxidant effects of risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Evaluation of neurotransmitter receptor gene expression identifies GABA receptor changes: a follow-up study in antipsychotic-naïve patients with first-episode psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Changes in gene expression and methylation in the blood of patients with first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Depressive symptoms in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

The evolution of depression and suicidality in first episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Circulating levels of sTNFR1 as a marker of severe clinical course in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Molecular and immunochemical evidences demonstrate that endooligopeptidase A is the predominant cytosolic oligopeptidase of rabbit brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Expression of DISC1-interactome members correlates with cognitive phenotypes related to schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Gene expression profiling in treatment-naive schizophrenia patients identifies abnormalities in biological pathways involving AKT1 that are corrected by antipsychotic medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

DISC1-NDEL1/NUDEL protein interaction, an essential component for neurite outgrowth, is modulated by genetic variations of DISC1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Inhibition of NUDEL (nuclear distribution element-like)-oligopeptidase activity by disrupted-in-schizophrenia 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Assessing the role of endooligopeptidase activity of Ndel1 (nuclear-distribution gene E homolog like-1) in neurite outgrowth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

COMT, neuropsychological function and brain structure in schizophrenia: a systematic review and neurobiological interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Depressive symptoms in first-episode psychosis: a 10-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Oxidant/antioxidant imbalance is an inherent feature of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

IL-6, IL-18, sIL-2R, and TNFα proinflammatory markers in depression and schizophrenia patients who are free of overt inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Effects of depression on the cytokine profile in drug naïve first-episode psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Differential activation of immune/inflammatory response-related co-expression modules in the hippocampus across the major psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

MicroRNA dysregulation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

MicroRNAs: Small molecules with big roles in neurodevelopment and diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Neuroplasticity signaling pathways linked to the pathophysiology of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

DISC1 regulates new neuron development in the adult brain via modulation of AKT-mTOR signaling through KIAA1212

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

The nuclear RNase III Drosha initiates microRNA processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Central nervous system myelin: structure, synthesis and assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Reduced myelin basic protein and actin-related gene expression in visual cortex in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Oligodendrocyte dysfunction in schizophrenia and bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Gene expression analysis in blood of ultra-high risk subjects compared to first-episode of psychosis patients and controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Upregulation of dicer and microRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Schizophrenia is associated with an increase in cortical microRNA biogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Transcriptome study of differential expression in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

MicroRNAs regulate brain morphogenesis in zebrafish

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12035-015-9489-3

Interleukin-6 regulation of the human DNA methyltransferase (HDNMT) gene in human erythroleukemia cells

21 January 2018

1 reference

12 December 2020

Assessing depression in schizophrenia: the Calgary Depression Scale

1 reference

12 December 2020

Plasma Ndel1 enzyme activity is reduced in patients with schizophrenia – A potential biomarker?

1 reference

12 December 2020

Neurotransmitter receptor and regulatory gene expression in peripheral blood of Brazilian drug-naïve first-episode psychosis patients before and after antipsychotic treatment

1 reference

12 December 2020

10.1007/S12035-015-9489-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26491028%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

5 June 2020

1008446604

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26491028%20AND%20SRC:MED&resulttype=core&format=json